Biomedical Engineering Reference
In-Depth Information
75. Rabinovich RA, Ardite E, Troosters T, Carbo N, Alonso J, Gonzalez de Suso
JM, et al. Reduced muscle redox capacity after endurance training in patients
with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;
164(7):1114-1118.
76. Bross R, Javanbakht M, Bhasin S. Anabolic interventions for aging-
associated sarcopenia. J Clin Endocrinol Metab 1999; 84(10):3420-3430.
77. Woods K, Marrone A, Smith J. Programmed cell death and senescence in
skeletal muscle stem cells. Ann N Y Acad Sci 2000; 908:331-335.
78. Morl` M, Busquets X, Pons J, Agust´ AGN. Accelerated ageing and chronic
obstructive pulmonary disease (COPD). Eur Respir J 2003; 22(suppl 45):195.
79. Moncada S, Higgs A. The l-arginine-nitric oxide pathway. N Engl J Med
1993; 329:2002-2012.
80. Kobzik L, Reid MB, Bredt DS, Stamler JS. Nitric oxide in skeletal muscle.
Nature 1994; 372:546-548.
81. Williams G, Brown T, Becker L, Prager M, Giroir BP. Cytokine-induced
expression of nitric oxide synthase in C2C12 skeletal muscle myocytes. Am
J Physiol 1994; 267(4 Pt 2):R1020-R1025.
82. Gari PG, Busquets X, Morl´ M, Sauleda J, Agusti AG. Upregulation of the
inducible form of the nitric oxide synthase and nitrotyrosine formation in ske-
letal muscle of COPD patients with cachexia. Eur Respir J 2002; 20(suppl 38):
211s.
83. Br ¨ne B, Von Knethen A, Sandau KB. Nitric oxide and its role in apoptosis.
Eur J Pharmacol 1998; 351:261-272.
84. Lanone S, Mebazaa A, Heymes C, Henin D, Poderoso JJ, Panis Y, et al.
Muscular contractile failure in septic patients: role of the inducible nitric oxide
synthase pathway. Am J Respir Crit Care Med 2000; 162(6):2308-2315.
85. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000;
343(4):269-280.
86. Cucina A, Sapienza P, Corvino V, Borrelli V, Mariani V, Randone B, et al.
Nicotine-induced smooth muscle cell proliferation is mediated through bFGF
and TGF-beta 1. Surgery 2000; 127:316-322.
87. Broal P. Main features of structure and function. In: Broal P, ed. The Central
Nervous System. New York: Oxford University Press, 1992:5-50.
88. Engelen MP, Schols AM, Lamers RJ, Wouters EF. Different patterns of
chronic tissue wasting among patients with chronic obstructive pulmonary
disease. Clin Nutr 1999; 18(5):275-280.
89. Silverman EK, Speizer FE, Weiss ST, Chapman HA Jr, Schuette A, Campbell
EJ, et al. Familial aggregation of severe, early-onset COPD: candidate gene
approaches. Chest 2000; 117(5 suppl 1):273S-274S.
90. Silverman EK, Chapman HA, Drazen JM, Weiss ST, Rosner B, Campbell EJ,
et al. Genetic epidemiology of severe, early-onset chronic obstructive pulmon-
ary disease—risk to relatives for airflow obstruction and chronic bronchitis.
Am J Respir Crit Care Med 1998; 157(6):1770-1778.
91. Williams AG, Rayson MP, Jubb M, World M, Woods DR, Hayward M, et al.
The ACE gene and muscle performance. Nature 2000; 403(6770):614.
92.
van Suylen RJ, Wouters EF, Pennings HJ, Cheriex EC, van Pol PE, Amber-
gen AW, et al. The DD genotype of the angiotensin converting enzyme gene is
